Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

High-degree atrioventricular block after radiation therapy

D J Kereiakes, F Morady, T A Ports

    The American Journal of Cardiology
    |April 1, 1983
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials.

    Heart (British Cardiac Society)·2003
    Same author

    The platelet function dose-response to abciximab during percutaneous coronary revascularization is variable.

    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2001
    Same author

    Differential effects of citrate versus PPACK anticoagulation on measured platelet inhibition by abciximab, eptifibatide and tirofiban.

    Journal of thrombosis and thrombolysis·2001
    Same author

    Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximab.

    American heart journal·2001
    Same author

    Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease.

    American heart journal·2001
    Same author

    Low molecular weight heparin therapy for percutaneous coronary intervention: a practice in evolution.

    Journal of thrombosis and thrombolysis·2001